(Total Views: 616)
Posted On: 10/07/2020 12:04:40 AM
Post# of 153822
“I have no medical or statistical training to know if the actual number of cases is 0, would that even begin to intuitively hint at efficacy of LL against Covid-19. Any opinions from our esteemed medically sophisticated members?”
IMO, the number of COVId infected patients among the current HIV population on leronlimab is irrelevant. Why? The sample is small. HIV patients are likely to protect themselves more from COVID19 (Lowe infection rate), and COVId infection isn’t part of the study. Additionally, CYDY can not afford another trial to look at COVID19 prevention for cost reasons and it would never be a very smart economic choice as you’d need multiple doses.
IMO, the number of COVId infected patients among the current HIV population on leronlimab is irrelevant. Why? The sample is small. HIV patients are likely to protect themselves more from COVID19 (Lowe infection rate), and COVId infection isn’t part of the study. Additionally, CYDY can not afford another trial to look at COVID19 prevention for cost reasons and it would never be a very smart economic choice as you’d need multiple doses.
(1)
(1)
